SUEROLYTE Oral Electrolyte Solution Pineapple Flavor
- Manufacturer
- Dannso Corp./d.b.a. Essential Products | Alfa Vitamins Laboratories Inc
- Effective date
- 2015-08-14
- Label type
- DIETARY SUPPLEMENT
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:48:16
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
STATEMENT OF IDENTITY SECTION
WARNINGS SECTION
Warnings
Do not use if neckband is broken or missing. Do not use if inner seal is broken or missing.
Ready to use. Do not add water. Store in a cool place. If experirncing vomitting, fever, or diarrhea continues beyond 24 hours, consult your physician.
Pregnancy / Breastfeeding: If pregnant or breastfeeding, ask a health professional before use.
DOSAGE & ADMINISTRATION SECTION
Directions
Children 1 year of age and older: offer solution every 15 minutes. The child should take from 1 to 2 liters per day while diarrhea continues.
Adults: can drink 1 to 2 fl. oz. every half hour, increasing the amount slowly. Reseal bottle with original cap.
Refrigerate and use within 48 hours.
Do not reuse container. Children under 1 year of age: consults physician before using.
Questions or Comments
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ANHYDROUS CITRIC ACID Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| SODIUM CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70242-121-33 | SUEROLYTE Oral Electrolyte Solution Pineapple Flavor | 1 L in 1 BOTTLE | LIQUID | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70242-121 | SUEROLYTE ORAL ELECTROLYTE SOLUTION PINEAPPLE FLAVOR ( DEXTROSE, CITRIC ACID, POTASSIUM CITRATE, SODIUM CHLORIDE,SODIUM CITRATE, SUCRALOSE, ACESULFAME POTASSIUM, ZINC GLUCONATE, POTASSIUM SORBATE) LIQUID [DANNSO CORP./D.B.A. ESSENTIAL PRODUCTS] | 1 | 1 package rows | 20160530_abaae728-8c07-4b00-8abe-71aa1a4ef514.zip |
Products#
Every source-derived product name is available through these pages.
- SUEROLYTE Oral Electrolyte Solution Pineapple Flavor
- Dextrose, Citric Acid, Potassium Citrate, Sodium Chloride,Sodium Citrate, Sucralose, Acesulfame Potassium, Zinc Gluconate, Potassium Sorbate
- DEXTROSE MONOHYDRATE
- ANHYDROUS DEXTROSE
- POTASSIUM CITRATE
- ANHYDROUS CITRIC ACID
- SODIUM CHLORIDE
- SODIUM CATION
- SODIUM CHLORITE
- CHLORITE ION
- ZINC
- Water
- Citric Acid MONOHYDRATE
- PINEAPPLE
- FD&C YELLOW NO. 6
- Sodium Citrate, UNSPECIFIED FORM
- Sucralose
- Acesulfame Potassium
- POTASSIUM SORBATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70242-121 | 70242-121-33 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DEXTROSE MONOHYDRATE | LX22YL083G | ACTIB |
| POTASSIUM CITRATE | EE90ONI6FF | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| SODIUM CHLORITE | G538EBV4VF | ACTIB |
| ZINC | J41CSQ7QDS | ACTIB |
| Water | 059QF0KO0R | IACT |
| Citric Acid MONOHYDRATE | 2968PHW8QP | IACT |
| PINEAPPLE | 2A88ZO081O | IACT |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| Sodium Citrate, UNSPECIFIED FORM | 1Q73Q2JULR | IACT |
| Sucralose | 96K6UQ3ZD4 | IACT |
| Acesulfame Potassium | 23OV73Q5G9 | IACT |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 8cf6943f-16e8-4521-863c-09bb0b55e2a9 | 2026-09-09 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | b8b77421-d687-45aa-82f6-d49bce644c10 | 2026-08-31 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 4ed365da-4e62-4329-c1b9-c197ab4fb6e1 | 2026-07-13 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 | 2026-06-11 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 10e98cb0-31a5-4ad1-3eaa-aa4af387a42d | 2026-06-02 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 40fd1ac4-39bb-45fb-ba99-4fb65481f231 | 2026-04-09 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | 8e7046f8-841e-465a-af69-af9fb3d6799d | 2026-03-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 3b8f2692-4371-4f1a-95af-b41842131fdd | 2026-03-13 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | BECTON DICKINSON AND COMPANY | 32132016-1870-481b-9816-e11beb03ca0b | 2026-01-08 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | bd250a46-d229-4e80-b5a1-b34169ccecc4 | 2025-12-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | 8b25b7e0-703e-4b43-a4eb-52863511602d | 2025-11-02 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | cb578dba-094c-4787-951d-763d12fd06e1 | 2025-11-01 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical Inc. | cdf35d11-fbc8-4f8e-85a8-33220312c0b4 | 2025-10-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3eff8bcd-6a33-428f-e063-6394a90afa68 | 2025-09-17 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | bfc4224a-2fc9-4137-b4c6-9d2d6d948413 | 2025-07-30 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3842a9c0-8b15-1c94-e063-6394a90ae120 | 2025-07-18 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 36e9478c-5df0-4b47-b97d-de3626d7cb29 | 2025-06-30 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | FRESENIUS KABI USA, LLC | 576a22d8-5f2f-497e-80ad-1842ca74bb53 | 2024-08-22 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | c1f72bce-4bef-49db-a8da-f26a703d6748 | 2024-08-15 | Warnings, Adverse reactions | DEXTROSE MONOHYDRATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
